These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 16678123)
1. ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion. Moss AC; Lawlor G; Murray D; Tighe D; Madden SF; Mulligan AM; Keane CO; Brady HR; Doran PP; MacMathuna P Biochem Biophys Res Commun; 2006 Jun; 345(1):216-21. PubMed ID: 16678123 [TBL] [Abstract][Full Text] [Related]
2. Two unique novel prostate-specific and androgen-regulated fusion partners of ETV4 in prostate cancer. Hermans KG; Bressers AA; van der Korput HA; Dits NF; Jenster G; Trapman J Cancer Res; 2008 May; 68(9):3094-8. PubMed ID: 18451133 [TBL] [Abstract][Full Text] [Related]
3. Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma. Takita J; Chen Y; Okubo J; Sanada M; Adachi M; Ohki K; Nishimura R; Hanada R; Igarashi T; Hayashi Y; Ogawa S Cancer Sci; 2011 Sep; 102(9):1645-50. PubMed ID: 21624008 [TBL] [Abstract][Full Text] [Related]
4. MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2. Lawlor G; Doran PP; MacMathuna P; Murray DW J Exp Clin Cancer Res; 2010 Jun; 29(1):81. PubMed ID: 20569498 [TBL] [Abstract][Full Text] [Related]
5. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs. Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710 [TBL] [Abstract][Full Text] [Related]
7. TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Tomlins SA; Mehra R; Rhodes DR; Smith LR; Roulston D; Helgeson BE; Cao X; Wei JT; Rubin MA; Shah RB; Chinnaiyan AM Cancer Res; 2006 Apr; 66(7):3396-400. PubMed ID: 16585160 [TBL] [Abstract][Full Text] [Related]
8. ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1. Tyagi N; Deshmukh SK; Srivastava SK; Azim S; Ahmad A; Al-Ghadhban A; Singh AP; Carter JE; Wang B; Singh S Mol Cancer Res; 2018 Feb; 16(2):187-196. PubMed ID: 29117940 [TBL] [Abstract][Full Text] [Related]
10. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687 [TBL] [Abstract][Full Text] [Related]
11. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells. Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613 [TBL] [Abstract][Full Text] [Related]
12. CXCR-4 knockdown by small interfering RNA inhibits cell proliferation and invasion of oral squamous cell carcinoma cells. Hong JS; Pai HK; Hong KO; Kim MA; Kim JH; Lee JI; Hong SP; Hong SD J Oral Pathol Med; 2009 Feb; 38(2):214-9. PubMed ID: 18624931 [TBL] [Abstract][Full Text] [Related]
13. ETV4 transcription factor and MMP13 metalloprotease are interplaying actors of breast tumorigenesis. Dumortier M; Ladam F; Damour I; Vacher S; Bièche I; Marchand N; de Launoit Y; Tulasne D; Chotteau-Lelièvre A Breast Cancer Res; 2018 Jul; 20(1):73. PubMed ID: 29996935 [TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity. Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479 [TBL] [Abstract][Full Text] [Related]
15. MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes. Koslowski M; Sahin U; Dhaene K; Huber C; Türeci O Cancer Res; 2008 May; 68(9):3458-66. PubMed ID: 18451174 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer. Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645 [TBL] [Abstract][Full Text] [Related]
17. RhoA mediates cyclooxygenase-2 signaling to disrupt the formation of adherens junctions and increase cell motility. Chang YW; Marlin JW; Chance TW; Jakobi R Cancer Res; 2006 Dec; 66(24):11700-8. PubMed ID: 17178865 [TBL] [Abstract][Full Text] [Related]
18. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins. Chaturvedi P; Singh AP; Moniaux N; Senapati S; Chakraborty S; Meza JL; Batra SK Mol Cancer Res; 2007 Apr; 5(4):309-20. PubMed ID: 17406026 [TBL] [Abstract][Full Text] [Related]
19. [Effects of allicin on invasion and metastasis of colon cancer LoVo cell line in vitro]. Gao Y; Liu YQ; Cao WK; Chen XF; Wan YY; Heng C; Xu LJ Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1382-6. PubMed ID: 19671326 [TBL] [Abstract][Full Text] [Related]
20. APRIL knockdown suppresses migration and invasion of human colon carcinoma cells. Ding W; Wang J; Sun B; Ju S; Yuan H; Wang X; Wang Y; Wang H Clin Biochem; 2009 Nov; 42(16-17):1694-8. PubMed ID: 19573525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]